Obesity and its management in primary care setting.
СтатьяОбзорПоддержка NIH: внешняя программаПоддержка службы здравоохранения СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ibrahim Mahmoud, Ba-Essa Ebtesam M, Alvarez Jessica A, Baker Jason, Bruni Vincenzo, Cahn Avivit, Ceriello Antonio, Cosentino Francesco, Davies Melanie J, De Domenico Francesco, Eckel Robert H, Friedman Allon N, Goldney Jonathan, Hamtzany Omer, Isaacs Scott, Karadeniz Sehnaz, Leslie Richard David, Lingvay Ildiko, McLaughlin Sue, Mobarak Omar, Del Prato Stefano, Prattichizzo Francesco, Rizzo Manfredi, Rötzer René D, le Roux Carel W, Schnell Oliver, Seferovic Petar M, Somers Virend K, Standl Eberhard, Thomas Abraham, Tuccinardi Dario, Valensi Paul, Umpierrez Guillermo E
Аннотация
Obesity is a worldwide epidemic affecting adults and children, regardless of their socioeconomic status. Significant progress has been made in understanding the genetic causes contributing to obesity, shedding light on a portion of cases worldwide. In young children with severe obesity however, recessive mutations, i.e., leptin or leptin receptor deficiency should be sought. Much more has been learned about the far-reaching impact of obesity on complications, including cardiovascular disease, liver and kidney dysfunction, diabetes, inflammation, hypertension, sleep, cancer, and the eye. Preventive strategies, particularly in children, are crucial for reducing obesity rates and mitigating its long-term complications. While dietary modifications and lifestyle changes remain the cornerstone of obesity prevention or treatment, recent advancements have introduced highly effective pharmacological options complementing weight-reduction surgery. Newer medications, like incretin-based therapies including glucagon-like peptide-1 agonists (GLP-1RA), have demonstrated remarkable efficacy in promoting weight loss, offering new insights into margining obesity-related conditions. Primary care providers, whether treating adults or children, play a pivotal role in preventing obesity, initiating treatment, and making onward referrals to specialists to assist in managing obesity and obesity-related complications.